SI2875000T1 - Ariletinilni derivati - Google Patents

Ariletinilni derivati

Info

Publication number
SI2875000T1
SI2875000T1 SI201330415A SI201330415A SI2875000T1 SI 2875000 T1 SI2875000 T1 SI 2875000T1 SI 201330415 A SI201330415 A SI 201330415A SI 201330415 A SI201330415 A SI 201330415A SI 2875000 T1 SI2875000 T1 SI 2875000T1
Authority
SI
Slovenia
Prior art keywords
arylethynyl
derivatives
arylethynyl derivatives
Prior art date
Application number
SI201330415A
Other languages
English (en)
Inventor
Georg Jaeschke
Lothar Lindemann
Heinz Stadler
Eric Vieira
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of SI2875000T1 publication Critical patent/SI2875000T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201330415A 2012-07-17 2013-07-12 Ariletinilni derivati SI2875000T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12176662 2012-07-17
EP13735315.7A EP2875000B1 (en) 2012-07-17 2013-07-12 Arylethynyl derivatives
PCT/EP2013/064747 WO2014012851A1 (en) 2012-07-17 2013-07-12 Arylethynyl derivatives

Publications (1)

Publication Number Publication Date
SI2875000T1 true SI2875000T1 (sl) 2017-01-31

Family

ID=48782352

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201330415A SI2875000T1 (sl) 2012-07-17 2013-07-12 Ariletinilni derivati

Country Status (36)

Country Link
US (2) US20150133505A1 (sl)
EP (1) EP2875000B1 (sl)
JP (1) JP6089104B2 (sl)
KR (1) KR101631041B1 (sl)
CN (1) CN104364233B (sl)
AR (1) AR091764A1 (sl)
AU (1) AU2013292142B2 (sl)
BR (1) BR112014029015A2 (sl)
CA (1) CA2871389C (sl)
CL (1) CL2014003160A1 (sl)
CO (1) CO7111256A2 (sl)
CR (1) CR20140531A (sl)
CY (1) CY1118205T1 (sl)
DK (1) DK2875000T3 (sl)
EA (1) EA026593B1 (sl)
ES (1) ES2600133T3 (sl)
HK (1) HK1202544A1 (sl)
HR (1) HRP20161691T1 (sl)
HU (1) HUE030177T2 (sl)
IL (1) IL236362A (sl)
LT (1) LT2875000T (sl)
MA (1) MA20150280A2 (sl)
MX (1) MX358998B (sl)
MY (1) MY167810A (sl)
NZ (1) NZ701849A (sl)
PE (1) PE20150184A1 (sl)
PH (1) PH12014502695B1 (sl)
PL (1) PL2875000T3 (sl)
PT (1) PT2875000T (sl)
RS (1) RS55313B1 (sl)
SG (1) SG11201407050UA (sl)
SI (1) SI2875000T1 (sl)
TW (1) TWI473799B (sl)
UA (1) UA114911C2 (sl)
WO (1) WO2014012851A1 (sl)
ZA (1) ZA201408514B (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA113223C2 (xx) * 2012-08-13 2016-12-26 Арилетинілпіримідини
EA026941B1 (ru) * 2012-10-18 2017-06-30 Ф. Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ МОДУЛЯТОРОВ АКТИВНОСТИ РЕЦЕПТОРА mGluR5
PE20180358A1 (es) 2015-06-03 2018-02-21 Hoffmann La Roche Derivados de etinilo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19546462A1 (de) * 1995-12-13 1997-06-19 Bayer Ag Diarylacetylenketone
SI1354875T1 (sl) 2003-05-19 2005-02-28 Les Laboratoires Servier NOV POSTOPEK SINTEZE (2S, 3aS, 7aS)-PERHIDROINDOL-2-KARBOKSILNE KISLINE IN NJENIH ESTROV TER UPORABA PRI SINTEZI PERINDOPRILA
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
WO2006048771A1 (en) 2004-11-04 2006-05-11 Addex Pharmaceuticals Sa Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
GB0510139D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
MX2009013169A (es) 2007-06-03 2010-04-30 Univ Vanderbilt Moduladores alostericos positivos del mglur5 benzamida y metodos de elaboracion y uso de los mismos.
CN101544892B (zh) * 2009-05-07 2012-10-03 石家庄诚志永华显示材料有限公司 一种合成二芳基乙炔类单体液晶的方法
US8420661B2 (en) 2010-04-13 2013-04-16 Hoffmann-La Roche Inc. Arylethynyl derivatives
CA2829170C (en) * 2011-04-26 2019-02-26 F. Hoffmann-La Roche Ag Ethynyl derivatives as positive allosteric modulators of the mglur5

Also Published As

Publication number Publication date
NZ701849A (en) 2016-07-29
JP2015527993A (ja) 2015-09-24
KR101631041B1 (ko) 2016-06-15
PH12014502695A1 (en) 2015-01-26
US20150133505A1 (en) 2015-05-14
CR20140531A (es) 2015-01-12
JP6089104B2 (ja) 2017-03-01
US9328090B2 (en) 2016-05-03
EP2875000B1 (en) 2016-09-21
HK1202544A1 (zh) 2015-10-02
CL2014003160A1 (es) 2015-03-13
PE20150184A1 (es) 2015-02-13
KR20150023766A (ko) 2015-03-05
PH12014502695B1 (en) 2015-01-26
PL2875000T3 (pl) 2017-03-31
ZA201408514B (en) 2015-12-23
TW201408655A (zh) 2014-03-01
WO2014012851A1 (en) 2014-01-23
ES2600133T3 (es) 2017-02-07
MY167810A (en) 2018-09-26
AR091764A1 (es) 2015-02-25
EA026593B1 (ru) 2017-04-28
CY1118205T1 (el) 2017-06-28
CA2871389A1 (en) 2014-01-23
CN104364233A (zh) 2015-02-18
CN104364233B (zh) 2016-06-22
IL236362A0 (en) 2015-02-26
EP2875000A1 (en) 2015-05-27
AU2013292142A1 (en) 2014-11-06
EA201492274A1 (ru) 2015-05-29
SG11201407050UA (en) 2014-11-27
HUE030177T2 (en) 2017-04-28
HRP20161691T1 (hr) 2017-02-24
BR112014029015A2 (pt) 2017-06-27
TWI473799B (zh) 2015-02-21
PT2875000T (pt) 2016-11-03
AU2013292142B2 (en) 2017-03-09
RS55313B1 (sr) 2017-03-31
MX358998B (es) 2018-09-12
UA114911C2 (uk) 2017-08-28
DK2875000T3 (en) 2016-10-24
CO7111256A2 (es) 2014-11-10
LT2875000T (lt) 2016-11-10
CA2871389C (en) 2020-08-25
IL236362A (en) 2017-12-31
MA20150280A2 (fr) 2015-08-31
MX2014014950A (es) 2015-03-09
US20160039787A1 (en) 2016-02-11

Similar Documents

Publication Publication Date Title
HUS2200040I1 (hu) Benzimidazol-prolin származékok
HK1205740A1 (en) Pyrrolotriazinone derivatives
HK1205508A1 (en) New bicyclicpyridine derivatives
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
PT2838883T (pt) Novos derivados de fenil-tetra-hidroisoquinolina
HK1207376A1 (en) Arylethynyl derivatives
HK1202544A1 (zh) 芳基乙炔基衍生物
PL2807172T3 (pl) Pochodne pirymidooksazocyny jako inhibitory mTOR